News Focus
News Focus
icon url

pgsd

12/16/23 8:18 AM

#656384 RE: sukus #656379

As ever completely pointless discussion to have unless further qualified and nothing more than speculative guesses. A random figure means nothing for example, I personally believe by the end of 2024 we will be approved in UK, USA, Germany and Canada, partnership (s) will be announced perhaps with upfront payments and milestone payments arranged and I expect we will have started on further trials including paediatric and Direct p2 trials. This is just IMO but shows IF these all happen then the pps will likely IMO be higher than $7.50, and this doesn't even address such possibilities as naked shorts or potential court settlements. Also, bear in mind we are most likely to be approved not just for nGBM but rGBM and potentially other types of brain cancers